Mosquito monitoring saves lives and money, analysis finds

Key points
- Cutting surveillance for mosquito-borne diseases would likely translate into an exponential increase in both the number of human cases and the health costs when a disease outbreak occurs, according to an analysis by Emory University.
- The Public Library of Science (PLoS) publishes the research, led by Emory disease ecologist Gonzalo Vazquez-Prokopec, Oct.
- "Our analysis shows that halting mosquito surveillance can increase the management costs of epidemics by more than 300 times, in comparison with sustained surveillance and early case detection," Vazquez-Prokopec says.
- The research was prompted by a U.S. government proposal last spring to slash funding for the vector-borne disease program of the Centers for Disease Control and Prevention.
Cutting surveillance for mosquito-borne diseases would likely translate into an exponential increase in both the number of human cases and the health costs when a disease outbreak occurs, according to an analysis by Emory University.
The Public Library of Science (PLoS) publishes the research, led by Emory disease ecologist Gonzalo Vazquez-Prokopec, Oct. 26.
"Our analysis shows that halting mosquito surveillance can increase the management costs of epidemics by more than 300 times, in comparison with sustained surveillance and early case detection," Vazquez-Prokopec says.
The research was prompted by a U.S. government proposal last spring to slash funding for the vector-borne disease program of the Centers for Disease Control and Prevention. Congress ultimately voted to retain the program's budget at the same levels for 2011.
"This analysis provides scientific-based evidence of the need for more funding of mosquito surveillance, not less," says Uriel Kitron, a co-author of the study and the chair of Emory's Department of Environmental Studies.
Diseases spread by mosquitoes and other blood-sucking vectors are a major public health risk worldwide. They include a wide variety of bacterial, parasitic and viral infections, such as malaria, West Nile Virus, dengue fever and Lyme disease.
The Emory analysis used data from two outbreaks of dengue fever in Cairns, Australia, that occurred in 2003 and 2009. (Dengue fever, an extremely debilitating viral disease spread by mosquitoes, can be fatal.) A mathematical model was applied to the Cairns data to evaluate the economic impact of hypothetical epidemic curves, plotted against different response times. A response within two weeks of the introduction of the pathogen was assumed to occur with active disease surveillance in place, and delays of six-to-eight weeks were assumed when active disease and vector surveillance were eliminated.
In Cairns, where mosquito surveillance is active, the reactions to the dengue fever outbreaks were rapid. The costs of the epidemics – including vector control, case diagnosis, blood screening and work days lost to disease – totaled U.S.$150,000 for the 2003 outbreak and $1.1 million for the 2009 outbreak.
The analysis showed that a delayed response of four-to-six weeks to both Cairns dengue outbreaks would have resulted in drastically escalated costs of up to U.S.$382 million. A slight increase in the virulence of the strain could have multiplied the cost by another 10 times.
Cairns has a tropical climate similar to South Florida, where a dengue fever outbreak occurred in 2009, Vazquez-Prokopec notes. "Predictions based on our analysis show that, if the Miami area had not had a surveillance system in place, the costs to control the Florida outbreak could have been higher than the entire U.S. budget for mosquito surveillance," he says.
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Infections, HIV & STIs →
NewsNew Therapies Mean HIV Patients Gain Longer Lives, Face New Challenges
New HIV therapies have prolonged lives and improved health for patients with HIV, but the treatments have also brought the longer-term effects of the disease into sharper focus. Patients with HIV are not only about…
19 May 2009
NewsStudy Examines Cost-Effectiveness of HIV Monitoring Strategy in Countries With Limited Resources
In a computer-based model evaluating the benefits and costs of three types of HIV disease monitoring strategies, early initiation of antiretroviral therapy and monitoring using the CD4 count, a measure of immune system…
24 September 2008
News"Blood-Free" Monitoring as Good as Blood Tests in Predicting the Course of AIDS
Researchers at the University of Pennsylvania School of Medicine have shown that monitoring treatment adherence to AIDS therapy is a simple blood-free way to monitor risk of disease progression. The international study…

